These 5 Stocks Under $10 Are Poised To Explode

Page 5 of 5

1. Anavex Life Sciences Corp. (NASDAQ:AVXL

Share Price as of December 14: $8.45
Share Price Upside Potential: 596.52%
Number of Hedge Funds: 9

Anavex Life Sciences Corp. (NASDAQ:AVXL) is a clinical-stage biopharmaceutical company that develops therapeutics for treating central nervous system diseases. Anavex Life Sciences Corp. (NASDAQ:AVXL)’s lead product is Anavex, which is used for the treatment of Alzheimer’s disease, Parkinson’s disease, and other central nervous system illnesses.

While Anavex Life Sciences Corp. (NASDAQ:AVXL) is down by 18%, it commands a consensus Buy rating on Wall Street with a $56 price target, implying a 596.52% upside potential. Anavex Life Sciences Corp. (NASDAQ:AVXL) is one of the stocks under $10 poised to explode, going by its ambitions in developing treatment options for Alzheimer’s.

At the end of the third quarter of 2023, 9 hedge funds from our database held stakes in Anavex Life Sciences Corp. (NASDAQ:AVXL). The total value of these positions amounted to approximately $10.35 million.

Follow Anavex Life Sciences Corp. (NASDAQ:AVXL)

[/company-follow-email]

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get  the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out our articles on 12 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates and Billionaire Paul Singer’s Recent Activist Targets and Top Stock Picks.

Page 5 of 5